RBFOX3 and Alzheimer disease: Consistent with a previous report [76], several AD cases and one MCI case had high levels of γH2AX immunoreactivity in a proportion of NeuN-negative cells (Additional file 1: Figure S3 and data not shown), whereas the control cases did not.